» Articles » PMID: 3140967

Patients As a Direct Source of Information on Adverse Drug Reactions

Overview
Journal BMJ
Specialty General Medicine
Date 1988 Oct 8
PMID 3140967
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

To determine whether patients should participate directly in detecting adverse reactions to drugs their ability to provide written reports of symptoms experienced during treatment with amoxycillin or trimethoprim-sulphamethoxazole was investigated. When compared with telephone interviews forms on which patients reported events were reliable (the observed agreement with the same statements posed during telephone calls was 85%, kappa = 0.56) and valid (sensitivity = 54%, specificity = 94%). Patients were also supplied with forms that invited them to report adverse reactions, and their perceptions were compared with those of a panel of experts, who were informed of all clinical events that had been reported during the detailed telephone interviews. Patients were more conservative than the experts in attributing clinical events to drug treatment. The extent of agreement varied and was notably poor for skin and bowel complaints (kappa = 0.13 in each case). The performance of event report forms and reaction report forms as instruments of detection was compared in a hypothetical situation in which the experts' views represented the "truth" about adverse reactions to a new drug. Event reporting had a higher sensitivity than reaction reporting (42% v 24%) but a lower specificity (58% v 98%). National centres monitoring adverse drug reactions should probably resist pressure to accept reports of reactions directly from the public, but a system based on large scale reporting of events might be valuable in aiding the early detection of symptomatic reactions to new drugs.

Citing Articles

A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review.

Ferreira-da-Silva R, Reis-Pardal J, Pinto M, Monteiro-Soares M, Sousa-Pinto B, Morato M Drug Saf. 2024; 47(12):1203-1224.

PMID: 39160354 PMC: 11554745. DOI: 10.1007/s40264-024-01470-0.


Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study.

Kampichit S, Srisuriyachanchai W, Pratipanawatr T, Jarernsiripornkul N Int J Clin Pharm. 2023; 46(2):401-410.

PMID: 38151687 DOI: 10.1007/s11096-023-01669-8.


Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community.

Robinson F, Wilkes S, Schaefer N, Goldstein M, Rice M, Gray J Ther Adv Drug Saf. 2023; 14:20420986221146418.

PMID: 36861041 PMC: 9969430. DOI: 10.1177/20420986221146418.


A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England.

Mokbel K, Daniels R, Weedon M, Jackson L In Vivo. 2022; 36(2):780-800.

PMID: 35241534 PMC: 8931874. DOI: 10.21873/invivo.12765.


Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.

Barnes J, Butler R Drug Saf. 2020; 43(11):1157-1170.

PMID: 32975740 DOI: 10.1007/s40264-020-00980-x.


References
1.
Feinstein A . Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests. Clin Pharmacol Ther. 1975; 17(1):104-16. DOI: 10.1002/cpt1975171104. View

2.
INMAN W . Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton. Br Med J (Clin Res Ed). 1981; 282(6271):1216-7. PMC: 1505289. DOI: 10.1136/bmj.282.6271.1216. View

3.
Borden E, Lee J . A methodologic study of post-marketing drug evaluation using a pharmacy-based approach. J Chronic Dis. 1982; 35(10):803-16. DOI: 10.1016/0021-9681(82)90092-3. View

4.
Fisher S, BRYANT S, Solovitz B, Kluge R . Patient-initiated postmarketing surveillance: a validation study. J Clin Pharmacol. 1987; 27(11):843-54. DOI: 10.1002/j.1552-4604.1987.tb05578.x. View

5.
Crombie I, Brown S, Hamley J . Postmarketing drug surveillance by record linkage in Tayside. J Epidemiol Community Health. 1984; 38(3):226-31. PMC: 1052357. DOI: 10.1136/jech.38.3.226. View